CMPX R&D Expense Growth
Compass Therapeutics · R&D Expense Growth
CMPX R&D Expense Growth
Latest reported32.18%period ending
CMPX FY R&D Growth (YoY) (0.00% → 32.18%)
Latest values, visible window
High-resolution chart · PNG
CMPX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 32.1832% | |
| 11.0756% | |
| 27.0794% | |
| 47.4996% | |
| 36.4533% | |
| -33.6095% | |
| -17.1471% | |
| 0% |